Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

431 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

NCT05564390

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 348 locations
View Trial Details
Recruiting

Personalized NK Cell Therapy in CBT

NCT02727803

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT07020533

Conditions
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +38 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

NCT04227847

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Dept. of Medicine, UAB ONeal Comprehensive Cancer Center Birmingham, Alabama, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
View all 53 locations
View Trial Details
Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT07422480

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope - Comprehensive Cancer Center (CCC) Duarte, California, United States
  • Providence Medical Group Santa Rosa, California, United States
  • Cancer & Blood Research Center Whittier, California, United States
View all 156 locations
View Trial Details
Recruiting

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

NCT07046078

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions